ES2609385T3 - Procedimiento de evaluación y sistema de análisis de un analito en el fluido corporal de un ser humano o un animal - Google Patents

Procedimiento de evaluación y sistema de análisis de un analito en el fluido corporal de un ser humano o un animal Download PDF

Info

Publication number
ES2609385T3
ES2609385T3 ES05026421.7T ES05026421T ES2609385T3 ES 2609385 T3 ES2609385 T3 ES 2609385T3 ES 05026421 T ES05026421 T ES 05026421T ES 2609385 T3 ES2609385 T3 ES 2609385T3
Authority
ES
Spain
Prior art keywords
time
analyte
measurement data
measurement values
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05026421.7T
Other languages
English (en)
Spanish (es)
Inventor
Arnulf Staib
Hans-Martin Kloetzer
Matthias Essenpreis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2609385T3 publication Critical patent/ES2609385T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1495—Calibrating or testing of in-vivo probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02—Operational features
    • A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
    • A61B5/743—Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Primary Health Care (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES05026421.7T 2005-12-03 2005-12-03 Procedimiento de evaluación y sistema de análisis de un analito en el fluido corporal de un ser humano o un animal Expired - Lifetime ES2609385T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05026421.7A EP1793321B1 (de) 2005-12-03 2005-12-03 Auswerteverfahren und Untersuchungssystem eines Analyten im Körperflüssigkeit eines Menschen oder Tieres

Publications (1)

Publication Number Publication Date
ES2609385T3 true ES2609385T3 (es) 2017-04-20

Family

ID=35965935

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05026421.7T Expired - Lifetime ES2609385T3 (es) 2005-12-03 2005-12-03 Procedimiento de evaluación y sistema de análisis de un analito en el fluido corporal de un ser humano o un animal

Country Status (6)

Country Link
US (1) US8734347B2 (enExample)
EP (2) EP1793321B1 (enExample)
JP (1) JP5031762B2 (enExample)
DK (1) DK1793321T3 (enExample)
ES (1) ES2609385T3 (enExample)
WO (1) WO2007062755A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7545272B2 (en) 2005-02-08 2009-06-09 Therasense, Inc. RF tag on test strips, test strip vials and boxes
EP2071339A3 (en) * 2007-12-12 2015-05-20 Sysmex Corporation System for providing animal test information and method of providing animal test information
US8657746B2 (en) * 2010-10-28 2014-02-25 Medtronic Minimed, Inc. Glucose sensor signal purity analysis
EP3434184B1 (en) * 2014-04-10 2021-10-27 DexCom, Inc. Glycemic urgency assessment and alerts interface

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4221848C2 (de) 1992-07-03 2001-04-12 Eckhard Salzsieder Verfahren und Anordnung zur selbsttätigen in situ Kalibrierung von intrakorporalen Glukosemeßeinrichtungen
US7624028B1 (en) * 1992-11-17 2009-11-24 Health Hero Network, Inc. Remote health monitoring and maintenance system
EP0910023A2 (de) 1997-10-17 1999-04-21 Siemens Aktiengesellschaft Verfahren und Anordnung zur neuronalen Modellierung eines dynamischen Systems mit nichtlinearem stochastischem Verhalten
JP3692751B2 (ja) * 1997-12-24 2005-09-07 松下電器産業株式会社 糖尿病判断機能付き血糖計
JPH11318872A (ja) * 1998-05-18 1999-11-24 Matsushita Electric Ind Co Ltd 糖尿病判断機能付き血糖計
US6925393B1 (en) 1999-11-18 2005-08-02 Roche Diagnostics Gmbh System for the extrapolation of glucose concentration
JP2001212114A (ja) * 2000-02-02 2001-08-07 Matsushita Electric Ind Co Ltd 血糖計
US7890295B2 (en) * 2000-02-23 2011-02-15 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
EP1309271B1 (en) * 2000-08-18 2008-04-16 Animas Technologies LLC Device for prediction of hypoglycemic events
KR20030031894A (ko) * 2001-02-05 2003-04-23 글루코센스 인코퍼레이티드 혈중 포도당 농도의 측정 방법
US7399277B2 (en) * 2001-12-27 2008-07-15 Medtronic Minimed, Inc. System for monitoring physiological characteristics
EP2301428B1 (en) * 2003-12-09 2016-11-30 Dexcom, Inc. Signal processing for continuous analyte sensor

Also Published As

Publication number Publication date
EP1793321A1 (de) 2007-06-06
EP1955232A1 (de) 2008-08-13
DK1793321T3 (en) 2017-01-16
WO2007062755A1 (de) 2007-06-07
US8734347B2 (en) 2014-05-27
US20080262333A1 (en) 2008-10-23
JP2009519048A (ja) 2009-05-14
JP5031762B2 (ja) 2012-09-26
EP1793321B1 (de) 2016-11-16

Similar Documents

Publication Publication Date Title
JP3242346U (ja) 生理学的測定値の非侵襲的監視のための装置、およびシステム
US12048530B2 (en) Method and apparatus for detecting false hypoglycemic conditions
ES2656212T3 (es) Sistema para la detección y control de la hipoglucemia
US10406286B2 (en) Closed loop control with reference measurement and methods thereof
Mazze et al. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis
US8585591B2 (en) Method and system for providing basal profile modification in analyte monitoring and management systems
EP2424435B1 (en) Performance reports associated with continuous sensor data from multiple analysis time periods
JP6453914B2 (ja) 皮膚組織中の検体の分圧の断続的な測定
US20090240440A1 (en) Non-Invasive Glucose Monitoring
JP2007014751A (ja) インスリン投与量調節のために糖尿病患者の体液について一連のグルコース濃度を評価する方法と装置
EP2217135A1 (en) Assessing residual insulin time
EP3236851A1 (en) Method and system for determining a blood glucose level for a patient
Block et al. Minimally-invasive and non-invasive continuous glucose monitoring systems: indications, advantages, limitations and clinical aspects
Klimek et al. History of glucose monitoring: past, present, future
EP2869763B1 (en) Glucose consumption monitor
ES2609385T3 (es) Procedimiento de evaluación y sistema de análisis de un analito en el fluido corporal de un ser humano o un animal
JP7620633B2 (ja) コンピュータで実現される糖尿病管理方法
WO2013141734A1 (ru) Способ и устройство неинвазивного контроля уровня глюкозы в крови
Rahul et al. FreeStyle® libre™ flash glucose monitoring system: a novel diagnostic technique for monitoring diabetes
US20230270362A1 (en) Continuous health monitoring system
EP4461217A1 (en) Monitoring a kidney-related condition
Klimek et al. Continuous glucose monitoring: review of promising technologies
Reusch Diabetes mellitus-monitoring at home and in the hospital
Dietiker-Moretti Continuous glucose monitoring system: a new tool to assess blood glucose concentrations in cats with diabetes mellitus
Kopecký et al. Research Article The Use of Continuous Glucose Monitoring Combined with Computer-Based eMPC Algorithm for Tight Glucose Control in Cardiosurgical ICU